2024-12-05 01:35:01,865 - INFO - [31m[1mWARNING: This is a development server. Do not use it in a production deployment. Use a production WSGI server instead.[0m
 * Running on http://127.0.0.1:5555
2024-12-05 01:35:01,865 - INFO - [33mPress CTRL+C to quit[0m
2024-12-05 01:36:08,045 - WARNING - Invalid data fields in: {'relation_type': 'prevent', 'entity1_type': 'study', 'entity1_name': 'Prospective Natural History Study', 'entity2_type': 'progression', 'entity2_name': 'disease progression'}
2024-12-05 01:36:08,046 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'Prospective Natural History Study', 'entity2_type': 'disease', 'entity2_name': 'Age-related macular degeneration'}
2024-12-05 01:36:08,046 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'Prospective Natural History Study', 'entity2_type': 'prognosis', 'entity2_name': 'disease progression'}
2024-12-05 01:36:08,047 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'Age-related macular degeneration', 'entity2_type': 'age_group', 'entity2_name': 'industrialized world beyond 50 years of age'}
2024-12-05 01:36:34,260 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'disease', 'entity2_name': 'age-related macular degeneration'}
2024-12-05 01:37:12,781 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'study', 'entity1_name': 'prospective, randomized controlled study', 'entity2_type': 'treatment', 'entity2_name': 'PDT and TTT'}
2024-12-05 01:37:12,783 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'study', 'entity1_name': 'prospective, randomized controlled study', 'entity2_type': 'body_part', 'entity2_name': 'retina'}
2024-12-05 01:37:29,464 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'Age-related macular degeneration', 'entity2_type': 'demographic', 'entity2_name': 'older Americans'}
2024-12-05 01:38:19,965 - WARNING - Invalid data fields in: {'relation_type': 'prognosis', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'symptom', 'entity2_name': 'irreversible severe loss of vision'}
2024-12-05 01:38:19,967 - WARNING - Invalid data fields in: {'relation_type': 'prognosis', 'entity1_type': 'disease', 'entity1_name': 'OHS', 'entity2_type': 'symptom', 'entity2_name': 'loss of vision in one or both eyes due to CNV'}
2024-12-05 01:38:19,968 - WARNING - Invalid data fields in: {'relation_type': 'prognosis', 'entity1_type': 'disease', 'entity1_name': 'idiopathic CNV', 'entity2_type': 'symptom', 'entity2_name': 'loss of vision'}
2024-12-05 01:38:19,968 - WARNING - Invalid data fields in: {'relation_type': 'comorbidity', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'disease', 'entity2_name': 'CNV'}
2024-12-05 01:38:19,968 - WARNING - Invalid data fields in: {'relation_type': 'comorbidity', 'entity1_type': 'disease', 'entity1_name': 'OHS', 'entity2_type': 'disease', 'entity2_name': 'CNV'}
2024-12-05 01:38:19,968 - WARNING - Invalid data fields in: {'relation_type': 'comorbidity', 'entity1_type': 'disease', 'entity1_name': 'idiopathic CNV', 'entity2_type': 'disease', 'entity2_name': 'CNV'}
2024-12-05 01:39:04,698 - WARNING - Invalid data fields in: {'relation_type': 'risk_factor', 'entity1_type': 'comorbidity', 'entity1_name': 'other conditions', 'entity2_type': 'disease', 'entity2_name': 'AMD'}
2024-12-05 01:39:12,450 - WARNING - Invalid data fields in: {'relation_type': 'risk_factor', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'symptom', 'entity2_name': 'low dietary intake or low blood levels of lutein and zeaxanthin'}
2024-12-05 01:39:42,698 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'laser photocoagulation', 'entity2_type': 'adverse_event', 'entity2_name': 'adverse events'}
2024-12-05 01:40:53,673 - WARNING - Failed to parse match: {'relation_type': 'cause', 'entity1_type': 'age', 'entity2_type': 'risk_factor', 'entity2_name': 'increases dramatically with age'}\n{'relation_type': 'present', 'entity1_type': 'disease', 'entity1_name': 'Age-related macular degeneration', 'entity2_type': 'biomarker', 'entity2_name': 'large drusen'}. Error: unexpected character after line continuation character (<unknown>, line 1)
2024-12-05 01:41:19,062 - WARNING - Invalid data fields in: {'relation_type': 'prognosis', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'progression', 'entity2_name': 'advanced AMD'}
2024-12-05 01:41:19,063 - WARNING - Invalid data fields in: {'relation_type': 'prognosis', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'progression', 'entity2_name': 'wet AMD'}
2024-12-05 01:41:19,063 - WARNING - Invalid data fields in: {'relation_type': 'prognosis', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'progression', 'entity2_name': 'GA'}
2024-12-05 01:41:29,915 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'disease', 'entity1_name': 'age-related macular degeneration', 'entity2_type': 'emotion', 'entity2_name': 'depression'}
2024-12-05 01:41:29,916 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'age-related macular degeneration', 'entity2_type': 'activity', 'entity2_name': 'reading a newspaper'}
2024-12-05 01:41:29,916 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'age-related macular degeneration', 'entity2_type': 'activity', 'entity2_name': 'recognizing facial expressions'}
2024-12-05 01:41:29,917 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'oculomotor training program', 'entity2_type': 'skill', 'entity2_name': 'reading'}
2024-12-05 01:41:29,917 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'macular disease', 'entity2_type': 'characteristic', 'entity2_name': 'visual acuity'}
2024-12-05 01:41:29,918 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'macular disease', 'entity2_type': 'characteristic', 'entity2_name': 'contrast sensitivity'}
2024-12-05 01:41:29,918 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'macular disease', 'entity2_type': 'characteristic', 'entity2_name': 'size of scotoma'}
2024-12-05 01:41:29,918 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'macular disease', 'entity2_type': 'characteristic', 'entity2_name': 'duration of the disease'}
2024-12-05 01:43:00,549 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'Bevacizumab', 'entity2_type': 'cost', 'entity2_name': 'low-cost'}
2024-12-05 01:43:00,552 - WARNING - Invalid data fields in: {'relation_type': 'present', 'entity1_type': 'treatment', 'entity1_name': 'Bevacizumab', 'entity2_type': 'characteristic', 'entity2_name': 'available in China'}
2024-12-05 01:43:00,552 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'Bevacizumab', 'entity2_type': 'safety', 'entity2_name': 'suitable treatment for China'}
2024-12-05 01:43:16,713 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'disease', 'entity1_name': 'neovascular age-related macular degeneration', 'entity2_type': 'condition', 'entity2_name': 'choroidal neovascularization'}
2024-12-05 01:43:16,714 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'condition', 'entity1_name': 'choroidal neovascularization', 'entity2_type': 'symptom', 'entity2_name': 'edema'}
2024-12-05 01:43:16,714 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'condition', 'entity1_name': 'choroidal neovascularization', 'entity2_type': 'symptom', 'entity2_name': 'hemorrhage'}
2024-12-05 01:43:23,081 - WARNING - Invalid data fields in: {'relation_type': 'involve', 'entity1_type': 'gene', 'entity1_name': 'TNF alpha', 'entity2_type': 'process', 'entity2_name': 'inflammation'}
2024-12-05 01:43:23,081 - WARNING - Invalid data fields in: {'relation_type': 'involve', 'entity1_type': 'gene', 'entity1_name': 'TNF alpha', 'entity2_type': 'process', 'entity2_name': 'retinal membrane formation'}
2024-12-05 01:43:29,419 - WARNING - Invalid data fields in: {'relation_type': 'hypothesize', 'entity1_type': 'study', 'entity1_name': 'The PrONTO study', 'entity2_type': 'difference', 'entity2_name': 'in benefit'}
2024-12-05 01:43:29,420 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'difference', 'entity1_name': 'in benefit', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:45:07,054 - WARNING - Invalid data fields in: {'relation_type': 'consist_of', 'entity1_type': 'biomarker', 'entity1_name': 'macular pigment', 'entity2_type': 'gene', 'entity2_name': 'lutein'}
2024-12-05 01:45:07,059 - WARNING - Invalid data fields in: {'relation_type': 'consist_of', 'entity1_type': 'biomarker', 'entity1_name': 'macular pigment', 'entity2_type': 'gene', 'entity2_name': 'zeaxanthin'}
2024-12-05 01:45:07,059 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'biomarker', 'entity1_name': 'macular pigment', 'entity2_type': 'light', 'entity2_name': 'short-wavelength light'}
2024-12-05 01:45:07,060 - WARNING - Invalid data fields in: {'relation_type': 'protect', 'entity1_type': 'biomarker', 'entity1_name': 'macular pigment', 'entity2_type': 'body_part', 'entity2_name': 'retina'}
2024-12-05 01:45:07,060 - WARNING - Invalid data fields in: {'relation_type': 'hypothesize', 'entity1_type': 'treatment', 'entity1_name': 'lutein supplementation', 'entity2_type': 'disease', 'entity2_name': 'Age-Related Macular Degeneration (AMD)'}
2024-12-05 01:45:07,060 - WARNING - Invalid data fields in: {'relation_type': 'investigate', 'entity1_type': 'study', 'entity1_name': 'The present study', 'entity2_type': 'treatment', 'entity2_name': '6 months lutein supplementation'}
2024-12-05 01:45:07,060 - WARNING - Invalid data fields in: {'relation_type': 'influence', 'entity1_type': 'treatment', 'entity1_name': '6 months lutein supplementation', 'entity2_type': 'biomarker', 'entity2_name': 'MP optical density (OD)'}
2024-12-05 01:45:07,060 - WARNING - Invalid data fields in: {'relation_type': 'influence', 'entity1_type': 'treatment', 'entity1_name': '6 months lutein supplementation', 'entity2_type': 'symptom', 'entity2_name': 'visual acuity'}
2024-12-05 01:45:07,061 - WARNING - Invalid data fields in: {'relation_type': 'influence', 'entity1_type': 'treatment', 'entity1_name': '6 months lutein supplementation', 'entity2_type': 'symptom', 'entity2_name': 'depth and dimension of central scotoma'}
2024-12-05 01:45:07,061 - WARNING - Invalid data fields in: {'relation_type': 'alter', 'entity1_type': 'treatment', 'entity1_name': '6 months lutein supplementation', 'entity2_type': 'symptom', 'entity2_name': 'symptoms in patients with AMD'}
2024-12-05 01:45:14,283 - WARNING - Invalid data fields in: {'relation_type': 'prevent', 'entity1_type': 'management', 'entity1_name': 'early management', 'entity2_type': 'complication', 'entity2_name': 'permanently lost photoreceptors'}
2024-12-05 01:45:33,426 - WARNING - Invalid data fields in: {'relation_type': 'combine', 'entity1_type': 'treatment', 'entity1_name': 'photodynamic therapy (PDT) with verteporfin', 'entity2_type': 'treatment', 'entity2_name': 'intravitreal triamcinolone acetonide (IVTA)'}
2024-12-05 01:45:33,427 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'reduced fluence', 'entity2_type': 'treatment', 'entity2_name': 'standard fluence'}
2024-12-05 01:45:33,427 - WARNING - Invalid data fields in: {'relation_type': 'aim', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'comparison', 'entity2_name': 'reduced fluence with standard fluence PDT using verteporfin and IVTA for CNV secondary to AMD'}
2024-12-05 01:45:51,448 - WARNING - Failed to parse match: {'relation_type': 'cause', 'entity1_type': 'complication', 'entity2_type': 'symptom', 'entity2_name': 'significant loss of vision'}\n{'relation_type': 'treat', 'entity1_type': 'treatment', 'entity1_name': 'intravitreal anti-VEGF agents', 'entity2_type': 'disease', 'entity2_name': 'neovascular AMD'}. Error: unexpected character after line continuation character (<unknown>, line 1)
2024-12-05 01:46:00,050 - WARNING - Invalid data fields in: {'relation_type': 'characterize', 'entity1_type': 'disease', 'entity1_name': 'wet AMD', 'entity2_type': 'condition', 'entity2_name': 'choroidal neovascularization (CNV)'}
2024-12-05 01:46:00,050 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'condition', 'entity1_name': 'CNV', 'entity2_type': 'symptom', 'entity2_name': 'rapid, disabling blindness'}
2024-12-05 01:46:00,051 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'intravitreal complement inhibitor (POT-4)', 'entity2_type': 'condition', 'entity2_name': 'CNV'}
2024-12-05 01:46:00,051 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'condition', 'entity2_name': 'chronic inflammation'}
2024-12-05 01:46:00,051 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'condition', 'entity1_name': 'CNV', 'entity2_type': 'condition', 'entity2_name': 'unrestrained complement activation'}
2024-12-05 01:46:00,051 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'condition', 'entity1_name': 'CNV', 'entity2_type': 'condition', 'entity2_name': 'complement activation'}
2024-12-05 01:46:38,869 - WARNING - Invalid data fields in: {'relation_type': 'present', 'entity1_type': 'disease', 'entity1_name': 'Age-related macular degeneration', 'entity2_type': 'form', 'entity2_name': 'non-exsudative form'}
2024-12-05 01:46:38,870 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'combination', 'entity1_name': 'rheohemapheresis and lutein supplementation', 'entity2_type': 'disease', 'entity2_name': 'non-exsudative form of macular degeneration'}
2024-12-05 01:46:45,108 - WARNING - Invalid data fields in: {'relation_type': 'hypothesize', 'entity1_type': 'biomarker', 'entity1_name': 'macular pigment', 'entity2_type': 'protect', 'entity2_name': 'vision loss'}
2024-12-05 01:46:45,108 - WARNING - Invalid data fields in: {'relation_type': 'study', 'entity1_type': 'objective', 'entity1_name': 'To study if the macular pigment optical density can be raised by lutein supplementation.', 'entity2_type': 'treatment', 'entity2_name': 'lutein supplementation'}
2024-12-05 01:46:45,109 - WARNING - Invalid data fields in: {'relation_type': 'study', 'entity1_type': 'objective', 'entity1_name': 'To study if lutein supplementation can stop or slow down the decrease in visual functions.', 'entity2_type': 'treatment', 'entity2_name': 'lutein supplementation'}
2024-12-05 01:46:45,109 - WARNING - Invalid data fields in: {'relation_type': 'intervention', 'entity1_type': 'treatment', 'entity1_name': '10 mg lutein per day', 'entity2_type': 'disease', 'entity2_name': 'early signs of age-related macular degeneration'}
2024-12-05 01:46:45,109 - WARNING - Invalid data fields in: {'relation_type': 'control', 'entity1_type': 'treatment', 'entity1_name': 'placebo', 'entity2_type': 'disease', 'entity2_name': 'early signs of age-related macular degeneration'}
2024-12-05 01:47:19,209 - WARNING - Invalid data fields in: {'relation_type': 'characterize', 'entity1_type': 'disease', 'entity1_name': 'dry AMD', 'entity2_type': 'biomarker', 'entity2_name': 'drusen'}
2024-12-05 01:47:19,210 - WARNING - Invalid data fields in: {'relation_type': 'characterize', 'entity1_type': 'disease', 'entity1_name': 'dry AMD', 'entity2_type': 'biomarker', 'entity2_name': 'atrophic changes in the RPE'}
2024-12-05 01:47:19,210 - WARNING - Invalid data fields in: {'relation_type': 'progress', 'entity1_type': 'disease', 'entity1_name': 'dry AMD', 'entity2_type': 'disease', 'entity2_name': 'GA'}
2024-12-05 01:47:19,211 - WARNING - Invalid data fields in: {'relation_type': 'block', 'entity1_type': 'treatment', 'entity1_name': 'OT-551', 'entity2_type': 'process', 'entity2_name': 'angiogenesis stimulated by VEGF'}
2024-12-05 01:47:19,211 - WARNING - Invalid data fields in: {'relation_type': 'block', 'entity1_type': 'treatment', 'entity1_name': 'OT-551', 'entity2_type': 'process', 'entity2_name': 'other growth factors'}
2024-12-05 01:47:40,507 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'study', 'entity1_name': 'LUCAS', 'entity2_type': 'treatment', 'entity2_name': 'Bevacizumab (Avastin) and Ranibizumab (Lucentis)'}
2024-12-05 01:47:40,508 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'study', 'entity1_name': 'LUCAS', 'entity2_type': 'efficacy', 'entity2_name': 'Bevacizumab (Avastin) and Ranibizumab (Lucentis)'}
2024-12-05 01:47:40,508 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'study', 'entity1_name': 'LUCAS', 'entity2_type': 'safety', 'entity2_name': 'Bevacizumab (Avastin) and Ranibizumab (Lucentis)'}
2024-12-05 01:47:40,508 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'LUCAS', 'entity2_type': 'disease', 'entity2_name': 'exudative (wet) AMD'}
2024-12-05 01:47:40,509 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'LUCAS', 'entity2_type': 'treatment', 'entity2_name': 'inject and extend protocol'}
2024-12-05 01:47:40,509 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'LUCAS', 'entity2_type': 'treatment', 'entity2_name': 'photodynamic therapy (PDT)'}
2024-12-05 01:47:51,448 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'other tests', 'entity2_type': 'disease', 'entity2_name': 'wet Age-related macular degeneration'}
2024-12-05 01:47:51,448 - WARNING - Invalid data fields in: {'relation_type': 'switch', 'entity1_type': 'treatment', 'entity1_name': 'ranibizumab', 'entity2_type': 'treatment', 'entity2_name': 'any other Anti vascUlar endothelial growth factor (anti VEGF) treatment'}
2024-12-05 01:47:51,448 - WARNING - Invalid data fields in: {'relation_type': 'follow_up', 'entity1_type': 'treatment', 'entity1_name': 'switch', 'entity2_type': 'treatment', 'entity2_name': 'any other Anti vascUlar endothelial growth factor (anti VEGF) treatment'}
2024-12-05 01:47:51,449 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'administered treatments', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:47:51,449 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'results of ocular and visual assessments', 'entity2_type': 'symptom', 'entity2_name': 'visual impairment'}
2024-12-05 01:47:51,449 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'medical history', 'entity2_type': 'comorbidity', 'entity2_name': 'other medical conditions'}
2024-12-05 01:47:51,449 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'demographics', 'entity2_type': 'body_part', 'entity2_name': 'patient characteristics'}
2024-12-05 01:49:09,453 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'ranibizumab', 'entity2_type': 'age_group', 'entity2_name': 'above 50 years old'}
2024-12-05 01:49:24,239 - WARNING - Invalid data fields in: {'relation_type': 'present', 'entity1_type': 'treatment', 'entity1_name': 'ranibizumab (Lucentis)', 'entity2_type': 'side_effect', 'entity2_name': 'raised eye pressure'}
2024-12-05 01:49:24,240 - WARNING - Invalid data fields in: {'relation_type': 'aggravate', 'entity1_type': 'side_effect', 'entity1_name': 'raised eye pressure', 'entity2_type': 'comorbidity', 'entity2_name': 'glaucoma'}
2024-12-05 01:49:24,241 - WARNING - Invalid data fields in: {'relation_type': 'prevent', 'entity1_type': 'treatment', 'entity1_name': 'acetazolamide (Diamox)', 'entity2_type': 'side_effect', 'entity2_name': 'eye pressure spikes'}
2024-12-05 01:50:11,855 - WARNING - Invalid data fields in: {'relation_type': 'prevent', 'entity1_type': 'evidence', 'entity1_name': 'Randomised Control Trials (RCT)', 'entity2_type': 'implementation', 'entity2_name': 'enhanced rehabilitation programmes'}
2024-12-05 01:50:11,863 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'two types of eccentric viewing training', 'entity2_type': 'treatment', 'entity2_name': 'conventional hospital-based low vision care'}
2024-12-05 01:50:28,853 - WARNING - Invalid data fields in: {'relation_type': 'progress', 'entity1_type': 'disease', 'entity1_name': 'dry AMD', 'entity2_type': 'disease', 'entity2_name': 'wet AMD'}
2024-12-05 01:50:28,854 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'research', 'entity1_name': 'new treatments', 'entity2_type': 'disease', 'entity2_name': 'AMD'}
2024-12-05 01:50:28,854 - WARNING - Invalid data fields in: {'relation_type': 'diagnose', 'entity1_type': 'procedure', 'entity1_name': 'dark adaptation protocol', 'entity2_type': 'disease', 'entity2_name': 'early to middle dry AMD'}
2024-12-05 01:50:28,855 - WARNING - Invalid data fields in: {'relation_type': 'monitor', 'entity1_type': 'procedure', 'entity1_name': 'dark adaptation protocol', 'entity2_type': 'disease', 'entity2_name': 'early to middle dry AMD'}
2024-12-05 01:50:28,855 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'dark adaptation', 'entity2_type': 'biomarker', 'entity2_name': 'visual acuity'}
2024-12-05 01:50:28,855 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'dark adaptation', 'entity2_type': 'biomarker', 'entity2_name': 'retinal features on ocular imaging'}
2024-12-05 01:50:28,856 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'dark adaptation', 'entity2_type': 'biomarker', 'entity2_name': 'genetic variants'}
2024-12-05 01:50:28,856 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'dark adaptation', 'entity2_type': 'biomarker', 'entity2_name': 'other biomarkers identified from biospecimens'}
2024-12-05 01:50:28,856 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'visual acuity', 'entity2_type': 'biomarker', 'entity2_name': 'retinal features on ocular imaging'}
2024-12-05 01:50:28,856 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'visual acuity', 'entity2_type': 'biomarker', 'entity2_name': 'genetic variants'}
2024-12-05 01:50:28,856 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'visual acuity', 'entity2_type': 'biomarker', 'entity2_name': 'other biomarkers identified from biospecimens'}
2024-12-05 01:50:28,856 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'retinal features on ocular imaging', 'entity2_type': 'biomarker', 'entity2_name': 'genetic variants'}
2024-12-05 01:50:28,856 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'retinal features on ocular imaging', 'entity2_type': 'biomarker', 'entity2_name': 'other biomarkers identified from biospecimens'}
2024-12-05 01:50:28,857 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'biomarker', 'entity1_name': 'genetic variants', 'entity2_type': 'biomarker', 'entity2_name': 'other biomarkers identified from biospecimens'}
2024-12-05 01:51:00,546 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'condition', 'entity1_name': 'posterior vitreomacular adhesion (VMA)', 'entity2_type': 'disease', 'entity2_name': 'exudative AMD'}
2024-12-05 01:51:00,548 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'condition', 'entity1_name': 'posterior vitreomacular adhesion (VMA)', 'entity2_type': 'symptom', 'entity2_name': 'poorly responsive CNV'}
2024-12-05 01:51:00,548 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'procedure', 'entity1_name': 'intravitreal injection of expansile gas and induction of posterior vitreous detachment', 'entity2_type': 'condition', 'entity2_name': 'posterior vitreomacular adhesion (VMA)'}
2024-12-05 01:51:00,548 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'procedure', 'entity1_name': 'intravitreal injection of expansile gas and induction of posterior vitreous detachment', 'entity2_type': 'symptom', 'entity2_name': 'visual outcome in exudative AMD'}
2024-12-05 01:51:00,549 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'condition', 'entity1_name': 'posterior vitreomacular adhesion (VMA)', 'entity2_type': 'complication', 'entity2_name': 'resistance to anti-VEGF therapy'}
2024-12-05 01:51:00,549 - WARNING - Invalid data fields in: {'relation_type': 'aggravate', 'entity1_type': 'condition', 'entity1_name': 'posterior vitreomacular adhesion (VMA)', 'entity2_type': 'symptom', 'entity2_name': 'poor visual outcome after anti-VEGF treatment'}
2024-12-05 01:51:00,549 - WARNING - Invalid data fields in: {'relation_type': 'prevent', 'entity1_type': 'procedure', 'entity1_name': 'intravitreal injection of expansile gas and induction of posterior vitreous detachment', 'entity2_type': 'complication', 'entity2_name': 'resistance to anti-VEGF therapy in neovascular AMD with posterior vitreomacular adhesion (VMA)'}
2024-12-05 01:51:00,549 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'procedure', 'entity1_name': 'intravitreal injection of expansile gas and induction of posterior vitreous detachment', 'entity2_type': 'symptom', 'entity2_name': 'visual outcome in neovascular AMD with posterior vitreomacular adhesion (VMA)'}
2024-12-05 01:51:00,550 - WARNING - Invalid data fields in: {'relation_type': 'assess', 'entity1_type': 'test', 'entity1_name': 'safety and tolerability of the intravitreal administration of Ranibizumab combined with intravitreous injection of expansile gas', 'entity2_type': 'treatment', 'entity2_name': 'intravitreal administration of Ranibizumab combined with intravitreous injection of expansile gas'}
2024-12-05 01:51:31,626 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'factor', 'entity1_name': 'inflammation', 'entity2_type': 'disease', 'entity2_name': 'GA'}
2024-12-05 01:51:31,627 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'age_group', 'entity2_name': 'people over age 65'}
2024-12-05 01:51:31,628 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'vision', 'entity2_name': 'central visual acuity'}
2024-12-05 01:51:31,628 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'vision', 'entity2_name': 'visual acuity'}
2024-12-05 01:51:31,628 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'GA', 'entity2_type': 'vision', 'entity2_name': 'vision loss'}
2024-12-05 01:51:31,629 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'sirolimus', 'entity2_type': 'vision', 'entity2_name': 'preserve vision'}
2024-12-05 01:51:31,629 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'sirolimus', 'entity2_type': 'vision', 'entity2_name': 'visual acuity'}
2024-12-05 01:51:31,630 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'sirolimus', 'entity2_type': 'age_group', 'entity2_name': 'people at least 56 years of age'}
2024-12-05 01:51:31,630 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'sirolimus', 'entity2_type': 'time', 'entity2_name': '1 year'}
2024-12-05 01:51:31,631 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'sirolimus', 'entity2_type': 'adverse_event', 'entity2_name': 'AEs'}
2024-12-05 01:52:04,052 - WARNING - Invalid data fields in: {'relation_type': 'risk', 'entity1_type': 'treatment', 'entity1_name': '2RT laser', 'entity2_type': 'complication', 'entity2_name': 'provide too much energy or too little energy'}
2024-12-05 01:52:06,855 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'procedure', 'entity1_name': 'vitrectomy', 'entity2_type': 'disease', 'entity2_name': 'age-related macular degeneration'}
2024-12-05 01:53:13,722 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'disease', 'entity2_name': 'Choroidal neovascularization'}
2024-12-05 01:53:13,723 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'disease', 'entity2_name': 'Macular Edema'}
2024-12-05 01:53:13,723 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'complication', 'entity2_name': 'Rubeosis Iridis'}
2024-12-05 01:53:13,723 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'complication', 'entity2_name': 'Neovascular Glaucoma'}
2024-12-05 01:53:13,723 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'complication', 'entity2_name': 'Proliferative Diabetic Retinopathy'}
2024-12-05 01:53:13,723 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'disease', 'entity2_name': 'Pseudoxanthoma elasticum'}
2024-12-05 01:53:13,723 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'disease', 'entity2_name': 'Pathologic myopia'}
2024-12-05 01:53:13,724 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'disease', 'entity2_name': 'Proliferative Diabetic Retinopathy'}
2024-12-05 01:53:13,724 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'VEGF driven ocular diseases'}
2024-12-05 01:53:13,724 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Retinal Vein Occlusion'}
2024-12-05 01:53:13,724 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Diabetic macular edema'}
2024-12-05 01:53:13,724 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Diabetes'}
2024-12-05 01:53:13,724 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Pseudoxanthoma elasticum'}
2024-12-05 01:53:13,734 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Pathologic myopia'}
2024-12-05 01:53:13,734 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Retinal Vein Occlusion'}
2024-12-05 01:53:13,735 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Diabetic macular edema'}
2024-12-05 01:53:13,735 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'Extended Clinical Protocol', 'entity2_type': 'risk_factor', 'entity2_name': 'Pseudoxanthoma elasticum'}
2024-12-05 01:53:54,482 - WARNING - Invalid data fields in: {'relation_type': 'risk_factor', 'entity1_type': 'ocular_characteristic', 'entity1_name': 'GA baseline size', 'entity2_type': 'progression', 'entity2_name': 'GA progression'}
2024-12-05 01:53:54,482 - WARNING - Invalid data fields in: {'relation_type': 'risk_factor', 'entity1_type': 'ocular_characteristic', 'entity1_name': 'FAF abnormalities', 'entity2_type': 'progression', 'entity2_name': 'GA progression'}
2024-12-05 01:53:54,482 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'DSGA study', 'entity2_type': 'prognosis', 'entity2_name': 'individual disease process'}
2024-12-05 01:53:54,483 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'DSGA study', 'entity2_type': 'prognosis', 'entity2_name': 'GA progression'}
2024-12-05 01:53:54,484 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'DSGA study', 'entity2_type': 'understanding', 'entity2_name': 'pathogenesis of GA'}
2024-12-05 01:53:54,484 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'DSGA study', 'entity2_type': 'identification', 'entity2_name': 'predictive markers'}
2024-12-05 01:53:54,484 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'DSGA study', 'entity2_type': 'prognostic assessment', 'entity2_name': 'individual disease process'}
2024-12-05 01:53:54,484 - WARNING - Invalid data fields in: {'relation_type': 'extension', 'entity1_type': 'study', 'entity1_name': 'DSGA study', 'entity2_type': 'study', 'entity2_name': 'FAM study'}
2024-12-05 01:54:08,400 - WARNING - Invalid data fields in: {'relation_type': 'correlate', 'entity1_type': 'test', 'entity1_name': 'single nucleotide polymorphisms', 'entity2_type': 'risk_factor', 'entity2_name': 'alterations in the gut metagenome'}
2024-12-05 01:54:15,573 - WARNING - Invalid data fields in: {'relation_type': 'characterize', 'entity1_type': 'disease', 'entity1_name': 'GA', 'entity2_type': 'biomarker', 'entity2_name': 'outer retinal atrophy'}
2024-12-05 01:54:15,574 - WARNING - Invalid data fields in: {'relation_type': 'aggravate', 'entity1_type': 'disease', 'entity1_name': 'GA', 'entity2_type': 'disease process', 'entity2_name': 'GA progression'}
2024-12-05 01:54:15,574 - WARNING - Invalid data fields in: {'relation_type': 'influence', 'entity1_type': 'risk_factor', 'entity1_name': 'GA baseline size', 'entity2_type': 'progression', 'entity2_name': 'GA progression'}
2024-12-05 01:54:15,574 - WARNING - Invalid data fields in: {'relation_type': 'influence', 'entity1_type': 'risk_factor', 'entity1_name': 'fundus autofluorescence (FAF) abnormalities', 'entity2_type': 'progression', 'entity2_name': 'GA progression'}
2024-12-05 01:54:15,574 - WARNING - Invalid data fields in: {'relation_type': 'identify', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'characteristic', 'entity2_name': 'specific characteristics'}
2024-12-05 01:54:15,574 - WARNING - Invalid data fields in: {'relation_type': 'allow', 'entity1_type': 'prognosis', 'entity1_name': 'identification of predictive markers', 'entity2_type': 'assessment', 'entity2_name': 'individual disease process'}
2024-12-05 01:54:41,111 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,111 - WARNING - Invalid data fields in: {'relation_type': 'study', 'entity1_type': 'study', 'entity1_name': 'randomized controlled multicentre open-label parallel arm study', 'entity2_type': 'treatment', 'entity2_name': 'bevacizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'study', 'entity1_type': 'study', 'entity1_name': 'randomized controlled multicentre open-label parallel arm study', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'assess', 'entity1_type': 'study', 'entity1_name': 'randomized controlled multicentre open-label parallel arm study', 'entity2_type': 'safety', 'entity2_name': 'non-inferiority'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'administer', 'entity1_type': 'study', 'entity1_name': 'randomized controlled multicentre open-label parallel arm study', 'entity2_type': 'treatment', 'entity2_name': 'intravitreal injection'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'allocate', 'entity1_type': 'study', 'entity1_name': 'randomized controlled multicentre open-label parallel arm study', 'entity2_type': 'treatment', 'entity2_name': 'bevacizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'allocate', 'entity1_type': 'study', 'entity1_name': 'randomized controlled multicentre open-label parallel arm study', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,112 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,113 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,113 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,113 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,113 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,113 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:41,113 - WARNING - Invalid data fields in: {'relation_type': 'compare', 'entity1_type': 'treatment', 'entity1_name': 'bevacizumab', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 01:54:52,476 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'age-related macular degeneration', 'entity2_type': 'demographic', 'entity2_name': 'life expectancy'}
2024-12-05 01:54:52,476 - WARNING - Invalid data fields in: {'relation_type': 'progression', 'entity1_type': 'disease', 'entity1_name': 'age-related macular degeneration', 'entity2_type': 'demographic', 'entity2_name': 'number of people'}
2024-12-05 01:54:52,476 - WARNING - Invalid data fields in: {'relation_type': 'diagnose', 'entity1_type': 'study', 'entity1_name': 'ASPREE-AMD study', 'entity2_type': 'disease', 'entity2_name': 'age-related macular degeneration'}
2024-12-05 01:54:52,476 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'ASPREE-AMD study', 'entity2_type': 'disease', 'entity2_name': 'age-related macular degeneration'}
2024-12-05 01:54:52,476 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'age-related macular degeneration', 'entity2_type': 'demographic', 'entity2_name': 'life expectancy'}
2024-12-05 01:54:52,476 - WARNING - Invalid data fields in: {'relation_type': 'progression', 'entity1_type': 'disease', 'entity1_name': 'age-related macular degeneration', 'entity2_type': 'demographic', 'entity2_name': 'number of people'}
2024-12-05 01:54:52,476 - WARNING - Invalid data fields in: {'relation_type': 'diagnose', 'entity1_type': 'study', 'entity1_name': 'ASPREE-AMD study', 'entity2_type': 'disease', 'entity2_name': 'age-related macular degeneration'}
2024-12-05 01:54:52,477 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'ASPREE-AMD study', 'entity2_type': 'disease', 'entity2_name': 'age-related macular degeneration'}
2024-12-05 01:55:04,520 - WARNING - Invalid data fields in: {'relation_type': 'present', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'phenotypic_characteristic', 'entity2_name': 'RPD'}
2024-12-05 01:55:04,520 - WARNING - Invalid data fields in: {'relation_type': 'associate', 'entity1_type': 'phenotypic_characteristic', 'entity1_name': 'RPD', 'entity2_type': 'disease', 'entity2_name': 'AMD'}
2024-12-05 01:55:04,520 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'phenotypic_characteristic', 'entity1_name': 'RPD', 'entity2_type': 'symptom', 'entity2_name': 'disease progression to geographic atrophy'}
2024-12-05 01:55:04,521 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'Reticular Pseudodrusen Progression Study', 'entity2_type': 'knowledge', 'entity2_name': 'RPD progression'}
2024-12-05 01:55:04,521 - WARNING - Invalid data fields in: {'relation_type': 'identify', 'entity1_type': 'study', 'entity1_name': 'Reticular Pseudodrusen Progression Study', 'entity2_type': 'marker', 'entity2_name': 'predictive markers of RPD progression'}
2024-12-05 01:55:04,521 - WARNING - Invalid data fields in: {'relation_type': 'identify', 'entity1_type': 'study', 'entity1_name': 'Reticular Pseudodrusen Progression Study', 'entity2_type': 'marker', 'entity2_name': 'development of AMD late stages'}
2024-12-05 01:55:39,741 - WARNING - Invalid data fields in: {'relation_type': 'reduce', 'entity1_type': 'treatment', 'entity1_name': 'Stereotactic Radiotherapy', 'entity2_type': 'risk_factor', 'entity2_name': 'need for injections'}
2024-12-05 01:56:06,574 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'symptom', 'entity1_name': 'central vision loss', 'entity2_type': 'activity', 'entity2_name': 'reading'}
2024-12-05 01:56:06,575 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'symptom', 'entity1_name': 'central vision loss', 'entity2_type': 'activity', 'entity2_name': 'driving'}
2024-12-05 01:56:06,575 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'symptom', 'entity1_name': 'central vision loss', 'entity2_type': 'activity', 'entity2_name': 'recognizing faces'}
2024-12-05 01:56:06,575 - WARNING - Invalid data fields in: {'relation_type': 'goal', 'entity1_type': 'research_project', 'entity1_name': 'research project', 'entity2_type': 'prognosis', 'entity2_name': 'improving vision'}
2024-12-05 01:56:06,575 - WARNING - Invalid data fields in: {'relation_type': 'goal', 'entity1_type': 'research_project', 'entity1_name': 'research project', 'entity2_type': 'prognosis', 'entity2_name': 'maintaining function and productivity'}
2024-12-05 01:56:12,943 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'training program', 'entity2_type': 'cost', 'entity2_name': 'extensive cost'}
2024-12-05 01:56:12,943 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'training program', 'entity2_type': 'resource', 'entity2_name': 'clinical resources required for vision rehabilitation'}
2024-12-05 01:56:12,943 - WARNING - Failed to parse match: {'relation_type': 'affect', 'entity1_type': 'treatment', 'entity1_name': 'training program', 'entity2_type': 'resource', 'entity2_name': 'clinical facilities and therapists\\' time'}. Error: unterminated string literal (detected at line 1) (<unknown>, line 1)
2024-12-05 01:56:12,944 - WARNING - Invalid data fields in: {'relation_type': 'prevent', 'entity1_type': 'treatment', 'entity1_name': 'training program', 'entity2_type': 'resource', 'entity2_name': 'activities requiring face-to-face contact'}
2024-12-05 01:56:52,963 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'condition', 'entity2_name': 'irreversible blindness'}
2024-12-05 01:56:52,964 - WARNING - Invalid data fields in: {'relation_type': 'subtype', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'disease', 'entity2_name': 'PCV'}
2024-12-05 01:56:52,965 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'conbercept', 'entity2_type': 'anatomical_outcome', 'entity2_name': 'anatomical outcomes'}
2024-12-05 01:56:52,965 - WARNING - Invalid data fields in: {'relation_type': 'involve', 'entity1_type': 'study', 'entity1_name': 'study', 'entity2_type': 'procedure', 'entity2_name': 'intravitreal injection'}
2024-12-05 01:56:52,966 - WARNING - Invalid data fields in: {'relation_type': 'involve', 'entity1_type': 'study', 'entity1_name': 'study', 'entity2_type': 'procedure', 'entity2_name': 'follow up appointments'}
2024-12-05 01:56:52,966 - WARNING - Invalid data fields in: {'relation_type': 'involve', 'entity1_type': 'study', 'entity1_name': 'study', 'entity2_type': 'assessment', 'entity2_name': 'assessment of vision, leakage, and fluid buildup'}
2024-12-05 01:56:52,966 - WARNING - Invalid data fields in: {'relation_type': 'fund', 'entity1_type': 'organization', 'entity1_name': 'National Natural Science Foundation of China', 'entity2_type': 'study', 'entity2_name': 'study'}
2024-12-05 01:56:52,966 - WARNING - Invalid data fields in: {'relation_type': 'fund', 'entity1_type': 'organization', 'entity1_name': 'Fundamental Research Funds of the State Key Laboratory of Ophthalmology', 'entity2_type': 'study', 'entity2_name': 'study'}
2024-12-05 01:57:04,715 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'disease', 'entity1_name': 'wet AMD', 'entity2_type': 'abnormality', 'entity2_name': 'abnormal blood vessels growing in the eye'}
2024-12-05 01:57:04,716 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'chemical', 'entity1_name': 'vascular endothelial growth factor (VEGF)', 'entity2_type': 'growth', 'entity2_name': 'growth of these blood vessels'}
2024-12-05 01:57:04,716 - WARNING - Invalid data fields in: {'relation_type': 'block', 'entity1_type': 'treatment', 'entity1_name': 'conbercept', 'entity2_type': 'chemical', 'entity2_name': 'VEGF-A, VEGF-B, VEGF-C and placenta growth factor (PlGF)'}
2024-12-05 01:57:04,716 - WARNING - Invalid data fields in: {'relation_type': 'block', 'entity1_type': 'treatment', 'entity1_name': 'ranibizumab', 'entity2_type': 'chemical', 'entity2_name': 'VEGF-A'}
2024-12-05 01:57:04,716 - WARNING - Invalid data fields in: {'relation_type': 'aim', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'comparison', 'entity2_name': 'comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration'}
2024-12-05 01:57:04,717 - WARNING - Invalid data fields in: {'relation_type': 'include', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'participant', 'entity2_name': 'patients aged 51–85 with active wet AMD in one eye'}
2024-12-05 01:57:04,717 - WARNING - Invalid data fields in: {'relation_type': 'involve', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'procedure', 'entity2_name': 'participants are randomly allocated to be treated with either conbercept or ranibizumab'}
2024-12-05 01:57:04,717 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'treatment', 'entity2_name': 'future treatment of AMD patients'}
2024-12-05 01:57:04,717 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'procedure', 'entity1_name': 'injection of any of the drugs', 'entity2_type': 'side effect', 'entity2_name': 'less severe side effects related to the pre-injection preparation procedure'}
2024-12-05 01:57:04,717 - WARNING - Invalid data fields in: {'relation_type': 'run', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'location', 'entity2_name': 'The First Hospital of Qiqihar City (China), The Second Affiliated Hospital of Harbin Medical University (China), Peking Union Medical College Hospital (China), The Third Affiliated Hospital of Qiqihar Medical University (China)'}
2024-12-05 01:57:04,718 - WARNING - Invalid data fields in: {'relation_type': 'start', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'time', 'entity2_name': 'May 2014'}
2024-12-05 01:57:04,718 - WARNING - Invalid data fields in: {'relation_type': 'end', 'entity1_type': 'study', 'entity1_name': 'this study', 'entity2_type': 'time', 'entity2_name': 'May 2016'}
2024-12-05 01:57:04,718 - WARNING - Invalid data fields in: {'relation_type': 'fund', 'entity1_type': 'organization', 'entity1_name': 'The First Hospital of Qiqihar City (China)', 'entity2_type': 'study', 'entity2_name': 'this study'}
2024-12-05 01:57:04,718 - WARNING - Invalid data fields in: {'relation_type': 'fund', 'entity1_type': 'organization', 'entity1_name': 'National Natural Science Foundation of China (China)', 'entity2_type': 'study', 'entity2_name': 'this study'}
2024-12-05 01:57:04,718 - WARNING - Invalid data fields in: {'relation_type': 'fund', 'entity1_type': 'organization', 'entity1_name': 'Research to Prevent Blindness (USA)', 'entity2_type': 'study', 'entity2_name': 'this study'}
2024-12-05 01:57:04,718 - WARNING - Invalid data fields in: {'relation_type': 'contact', 'entity1_type': 'person', 'entity1_name': 'Dr Jinglin Cui', 'entity2_type': 'study', 'entity2_name': 'this study'}
2024-12-05 01:57:13,626 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'condition', 'entity1_name': 'hypoxia', 'entity2_type': 'disease', 'entity2_name': 'AMD'}
2024-12-05 01:57:13,628 - WARNING - Invalid data fields in: {'relation_type': 'prevent', 'entity1_type': 'treatment', 'entity1_name': 'low-level night-time light therapy', 'entity2_type': 'condition', 'entity2_name': 'hypoxia'}
2024-12-05 01:57:13,628 - WARNING - Invalid data fields in: {'relation_type': 'assess', 'entity1_type': 'study', 'entity1_name': 'the study', 'entity2_type': 'aspect', 'entity2_name': 'safety of this treatment'}
2024-12-05 01:57:13,629 - WARNING - Invalid data fields in: {'relation_type': 'aim', 'entity1_type': 'study', 'entity1_name': 'the study', 'entity2_type': 'outcome', 'entity2_name': 'slow the progression of AMD'}
2024-12-05 01:57:13,629 - WARNING - Invalid data fields in: {'relation_type': 'fund', 'entity1_type': 'organization', 'entity1_name': 'College of Optometrists', 'entity2_type': 'study', 'entity2_name': 'the study'}
2024-12-05 01:57:13,629 - WARNING - Invalid data fields in: {'relation_type': 'provide', 'entity1_type': 'organization', 'entity1_name': 'Polyphotonix Medical Ltd.', 'entity2_type': 'resource', 'entity2_name': 'masks'}
2024-12-05 01:57:13,629 - WARNING - Invalid data fields in: {'relation_type': 'contact', 'entity1_type': 'person', 'entity1_name': 'Dr Alison Binns', 'entity2_type': 'role', 'entity2_name': 'main contact'}
2024-12-05 01:57:38,633 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'diagnosis', 'entity2_name': 'retinal and choroidal abnormalities'}
2024-12-05 01:57:38,635 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'non-invasive'}
2024-12-05 01:57:38,635 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'diagnosis'}
2024-12-05 01:57:38,636 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'monitoring'}
2024-12-05 01:57:38,636 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'retinal and choroidal abnormalities'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'three dimensional'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'volumetric reflectivity information'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'transparent media'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'in vivo'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'high choroidal penetration'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'resolution'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'comparable to an histologic examination'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'infrared light sources'}
2024-12-05 01:57:38,637 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'ideal method'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'diagnosis'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'monitoring'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'retinal and choroidal abnormalities'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'three dimensional'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'volumetric reflectivity information'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'transparent media'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'in vivo'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'high choroidal penetration'}
2024-12-05 01:57:38,638 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'test', 'entity1_name': 'OCT', 'entity2_type': 'characteristic', 'entity2_name': 'resolution'}
2024-12-05 01:57:48,056 - WARNING - Invalid data fields in: {'relation_type': 'treat', 'entity1_type': 'study', 'entity1_name': 'APGS', 'entity2_type': 'disease', 'entity2_name': 'AMD'}
2024-12-05 01:57:51,339 - WARNING - Invalid data fields in: {'relation_type': 'investigate', 'entity1_type': 'research', 'entity1_name': 'relevant research', 'entity2_type': 'mechanism', 'entity2_name': 'immunological mechanism'}
2024-12-05 01:57:51,343 - WARNING - Invalid data fields in: {'relation_type': 'investigate', 'entity1_type': 'research', 'entity1_name': 'relevant research', 'entity2_type': 'mechanism', 'entity2_name': 'regulatory mechanism'}
2024-12-05 01:57:51,344 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'mechanism', 'entity1_name': 'immunological mechanism', 'entity2_type': 'disease', 'entity2_name': 'Age-related macular degeneration'}
2024-12-05 01:57:51,344 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'mechanism', 'entity1_name': 'regulatory mechanism', 'entity2_type': 'disease', 'entity2_name': 'Age-related macular degeneration'}
2024-12-05 01:58:23,953 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'factor', 'entity1_name': 'harmful blue light', 'entity2_type': 'disease', 'entity2_name': 'AMD'}
2024-12-05 01:58:23,953 - WARNING - Invalid data fields in: {'relation_type': 'cause', 'entity1_type': 'factor', 'entity1_name': 'damaging unstable molecules', 'entity2_type': 'disease', 'entity2_name': 'AMD'}
2024-12-05 01:59:08,648 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'establishing resistant/sensitive patients to treatment', 'entity2_type': 'response', 'entity2_name': 'to treatment'}
2024-12-05 01:59:20,221 - WARNING - Invalid data fields in: {'relation_type': 'evaluate', 'entity1_type': 'test', 'entity1_name': 'OCT angiography', 'entity2_type': 'disease', 'entity2_name': 'NVAMD'}
2024-12-05 02:00:05,692 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'Age-related macular degeneration', 'entity2_type': 'socioeconomic', 'entity2_name': 'impact'}
2024-12-05 02:00:05,693 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'Age-related macular degeneration', 'entity2_type': 'incidence', 'entity2_name': 'increased'}
2024-12-05 02:00:05,693 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'Age-related macular degeneration', 'entity2_type': 'prevalence', 'entity2_name': 'increased'}
2024-12-05 02:00:13,594 - WARNING - Invalid data fields in: {'relation_type': 'switch', 'entity1_type': 'treatment', 'entity1_name': 'ranibizumab', 'entity2_type': 'treatment', 'entity2_name': 'any other Anti-vascular Endothelial growth factor (anti-VEGF) treatment'}
2024-12-05 02:00:13,598 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'ocular and visual assessments', 'entity2_type': 'disease', 'entity2_name': 'wet Age-related macular degeneration'}
2024-12-05 02:00:13,598 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'other tests', 'entity2_type': 'disease', 'entity2_name': 'wet Age-related macular degeneration'}
2024-12-05 02:00:13,598 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'administered treatments', 'entity2_type': 'treatment', 'entity2_name': 'ranibizumab'}
2024-12-05 02:00:13,598 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'medical history', 'entity2_type': 'comorbidity', 'entity2_name': 'age-related macular degeneration'}
2024-12-05 02:00:13,598 - WARNING - Invalid data fields in: {'relation_type': 'document', 'entity1_type': 'test', 'entity1_name': 'demographics', 'entity2_type': 'body_part', 'entity2_name': 'patient'}
2024-12-05 02:00:39,071 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'quality_of_life', 'entity2_name': 'quality of life'}
2024-12-05 02:00:39,072 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'emotional_status', 'entity2_name': 'emotional status'}
2024-12-05 02:00:39,072 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'cognitive_ability', 'entity2_name': 'cognitive abilities'}
2024-12-05 02:00:39,072 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'cost', 'entity2_name': 'follow-up cost'}
2024-12-05 02:00:39,073 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'depression', 'entity2_name': 'depression'}
2024-12-05 02:00:39,073 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'depression', 'entity1_name': 'depression', 'entity2_type': 'cognitive_ability', 'entity2_name': 'cognitive decline'}
2024-12-05 02:00:39,073 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'activity', 'entity2_name': 'reading activity'}
2024-12-05 02:00:39,073 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'activity', 'entity2_name': 'driving activity'}
2024-12-05 02:00:39,073 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'activity', 'entity2_name': 'manual labor and work activity'}
2024-12-05 02:00:39,073 - WARNING - Invalid data fields in: {'relation_type': 'affect', 'entity1_type': 'disease', 'entity1_name': 'AMD', 'entity2_type': 'activity', 'entity2_name': 'television activity'}
2024-12-05 02:00:39,074 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'visual rehabilitation', 'entity2_type': 'emotional_status', 'entity2_name': 'emotional and cognitive status'}
2024-12-05 02:00:39,074 - WARNING - Invalid data fields in: {'relation_type': 'improve', 'entity1_type': 'treatment', 'entity1_name': 'visual rehabilitation', 'entity2_type': 'quality_of_life', 'entity2_name': 'quality of life'}
2024-12-05 02:00:48,591 - INFO - 127.0.0.1 - - [05/Dec/2024 02:00:48] "POST /api/upload_abstract HTTP/1.1" 200 -
2024-12-05 02:05:57,286 - INFO - 127.0.0.1 - - [05/Dec/2024 02:05:57] "GET /api/available_repositories HTTP/1.1" 200 -
2024-12-05 02:06:24,207 - INFO - 127.0.0.1 - - [05/Dec/2024 02:06:24] "POST /api/upload_relations HTTP/1.1" 200 -
